XML 8 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Feb. 13, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2025    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Trading Symbol AMSF    
Entity Registrant Name AMERISAFE, INC.    
Entity Central Index Key 0001018979    
Entity Current Reporting Status Yes    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Filer Category Large Accelerated Filer    
Document Annual Report true    
Document Transition Report false    
Entity Shell Company false    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity File Number 001-12251    
Entity Tax Identification Number 75-2069407    
Entity Address, Address Line One 2301 Highway 190 West    
Entity Address, City or Town DeRidder    
Entity Address, State or Province LA    
Entity Address, Postal Zip Code 70634    
City Area Code 337    
Local Phone Number 463-9052    
Entity Common Stock, Shares Outstanding   18,794,881  
Entity Public Float     $ 819.6
Entity Incorporation, State or Country Code TX    
Title of 12(b) Security Common stock, par value $0.01 per share    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Auditor Name Ernst & Young LLP    
Auditor Location New Orleans, Louisiana    
Auditor Firm ID 42    
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s Proxy Statement relating to the 2026 Annual Meeting of Shareholders are incorporated by reference in Items 10, 11, 12, 13 and 14 of Part III of this report.

    
Auditor Opinion [Text Block]

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of AMERISAFE, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of income, comprehensive income, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2025, and the related notes and financial statement schedules listed in the Index at Item 15 (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 27, 2026 expressed an unqualified opinion thereon.